Ruggero Cascio Ingurgio

11PUBLICATIONS
54CO-AUTHORS
Molecular targetsEpidemiological methodsAllergyCancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 01, 2026
Long-Term Disease Control During Continuous Treatment with Upadacitinib and Baricitinib for Moderate-to-Severe Atopic Dermatitis: a Real-World Monocentric Retrospective Study.

|Sep 25, 2026
Real-World Effectiveness of Lebrikizumab in Patients With Head-Neck Atopic Dermatitis: A Multicenter Study With Focus on Flare Occurrence.

|Jul 13, 2026
Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study.

|Jul 03, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

|Jun 01, 2026
Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trial.

|Apr 18, 2026
Selective IL-23 Inhibition in Conventional Treatment-Refractory Pyoderma Gangrenosum: A Multicenter, Retrospective Study.

Pageof 2

Frequent Collaborators

7 joint publications

Luigi Gargiulo

5 joint publications

Luciano Ibba

5 joint publications

Dedee F Murrell

4 joint publications

Angela Alfano